Caspase-dependent apoptosis during infection with Cryptosporidium parvum

Microbes and Infection

Volumn 1, Issue 14, 1999, Pages 1163-1168

  Ojcius, David M ^a   Perfettini, Jean Luc ^a   Bonnin, Alain ^b,c   Laurent, Fabrice ^d  

^a CNRS   (France)

^b HÔPITAL DU BOCAGE   (France)

^c UNIVERSITÉ DE BOURGOGNE   (France)

^d CEMAGREF   (France)

Author keywords

Apoptosis; Infectious immunity parasites; Protozoan parasites

Indexed keywords

CASPASE; CASPASE INHIBITOR; DNA FRAGMENT;

APOPTOSIS; ARTICLE; CELL COUNT; CHROMATIN CONDENSATION; CRYPTOSPORIDIUM PARVUM; CYTOLYSIS; DIARRHEA; HOST PARASITE INTERACTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MALNUTRITION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; WASTING SYNDROME;

EID: 0032795715     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(99)00246-4     Document Type: Article

References (47)

1. Stiehm E.R., Clin T.W., Hass A., Peerless A.G. Infectious complications of the primary immunodeficiencies. Clin. Immunol. Immunopathol. 40:1986;69-86.
2. Current W.L., Garcia L.S. Cryptosporidiosis. Clin. Microbiol. Rev. 4:1991;325-358.
3. Goodgame R.W. Understanding intestinal spore-forming protozoa: cryptosporidia, microsporidia, isospora, and cyclospora. Ann. Intern. M. 124:1996;429-441.
4. Sterling C.R., Arrowood M.J. Cryptosporidia. Parasitic Protozoa. 6:1993;159-225.
5. Laurent F., McCole D., Eckmann L., Kagnoff M.F. Pathogenesis of Cryptosporidium parvum infection. Microbes Infect. 1:1999;141-148.
6. Taghi-Kilani R., Sekla L., Hayglass K.T. The role of humoral immunity in Cryptosporidium spp. infection. J. Immunol. 145:1990;1571-1576.
7. McDonald V., Bancroft G.J. Immunological control of Cryptosporidium infection. Liew F.Y, Cox F.E.G. Immunology of Intracellular Parasitism. 1998;103-123 Basel, Karger.
8. Kuhls T.L., Greenfield R.A., Mosier D.A., Crawford D.L., Joyce W.A. Cryptosporidiosis in adult and neonatal mice with severe combined immunodeficiency. J. Comp. Pathol. 106:1992;399-410.
9. Aguirre S.A., Mason P.H., Perryman L.E. Susceptibility of major histocompatibility complex (MHC) class I- and class II-deficient mice to Cryptosporidium parvum infection. Infect. Immun. 62:1994;697-699.
10. Cosyns M., Tsirkin S., Jones M., Flavell R., Kikutani H., Hayward A.R. Requirement of CD40-CD40 ligand interaction for elimination of Cryptosporidium parvum from mice. Infect. Immun. 66:1998;603-607.
11. Petersen C. Cryptosporidiosis in patients infected with the human immunodeficiency virus. Clin. Infect. Dis. 15:1992;903-909.
12. Griffiths J.K., Moore R., Dooley S., Keusch G.T., Tzipori S. Cryptosporidium parvum infection of Caco-2 cell monolayers induces an apical monolayer defect selectively increases transmonolayer permeability and causes epithelial cell death. Infect. Immun. 62:1994;4506-4514.
13. Laurent F., Eckmann L., Savidge T.C., Morgan G., Theodos C., Naciri M., Kagnoff M.F. Cryptosporidium parvum infection of human intestinal epithelial cells induces the polarized secretion of C-X-C chemokines. Infect. Immun. 65:1997;5067-5073.
14. Jones R.A., Johnson V.L., Buck N.R., Dobrota M., Hinton R.H., Chow S.C., Kass G.E. Fas-mediated apoptosis in mouse hepatocytes involves the processing and activation of caspases. Hepatolology. 27:1998;1632-1642.
15. Rouquet N., Pages J.C., Molina T., Briand P., Joulin V. ICE inhibitor YVADcmk is a potent therapeutic agent against in vivo liver apoptosis. Curr. Biol. 6:1996;1192-1195.
16. Suzuki A. The dominant role of CPP32 subfamily in fas-mediated hepatitis. Proc. Soc. Exp. Biol. M. 217:1998;450-454.
17. Kunstle G., Leist M., Uhlig S., Revesz L., Feifel R., Mackenzie A., Wendel A. ICE-protease inhibitors block murine liver injury and apoptosis caused by CD95 or by TNFα Immunol. Lett. 55:1997;5-10.
18. Rodriguez I., Matsuura K., Ody C., Nagata S., Vassalli P. Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death. J. Exp. M. 184:1996;2067-2072.
19. Bonnin A., Dubremetz J.F., Camerlynck P. Characterization and immunolocalization of an oocyst wall antigen of Cryptosporidium parvum (Protozoa: apicomplexa). Parasitology. 103:1991;171-177.
20. Arnaud-Battandier F., Naciri M., Fischer C., Ricou C., Griscelli C., Yvore P. Cryptosporidiose intestinale: une cause nouvelle de diarrhée chez l'homme? Gastroenterol. Clin. Biol. 12:1982;1045-1046.
21. Ojcius D.M., Bravo D.E., Alba Y., Kanellopoulos J.M., Hawkins R.A., Kelly K.A., Rank R.G., Dautry-Varsat A. Internalization of Chlamydia by dendritic cells and stimulation of Chlamydia-specific T cells. J. Immunol. 160:1998;1297-1303.
22. Douglas R.S., Tarshis A.D., Pletcher C.H., Nowell P.C., Moore J.S. A simplified method for the coordinate examination of apoptosis and surface phenotype of murine lymphocytes. J. Immunol. Meth. 188:1995;219-228.
23. Ojcius D.M., Souque P., Perfettini J.L., Dautry-Varsat A. Apoptosis of epithelial cells and macrophages due to infection with the obligate intracellular pathogen Chlamydia psittaci. J. Immunol. 161:1998;4220-4226.
24. Susin S.A., Zanzami N., Larochette N., Dallaporta B., Marzo I., Brenner C. A cytofluorometric assay of nuclear apoptosis induced in a cell-free system: application to ceramide-induced apoptosis. Exp. Cell Res. 236:1997;397-403.
25. Samejima K., Toné S., Kottke T.J., Enari M., Sakahira H., Cooke C.A., Durrieu F., Martins L.M., Nagata S., Kaufmann S.H., Earnshaw W.C. Transition from caspase-dependent to caspase-independent mechanisms at the onset of apoptotic execution. J. Cell Biol. 143:1998;225-239.
26. Wyllie A.H., Kerr J.F., Currie A.R. Cell death: the significance of apoptosis. Int. Rev. Cytol. 68:1980;251-306.
27. Liu X., Zou H., Slaughter C., Wang X. DFF a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell. 89:1997;175-184.
28. Enari M., Sakahira H., Yokoyama H., Okawa K., Iwamatsu A., Nagata S. A caspase-activated DNase that degrades DNA during apoptosis and its inhibitor ICAD. Nature. 391:1998;43-50.
29. Sakahira H., Enari M., Nagata S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature. 391:1998;96-99.
30. Armstrong R.C., Aja T., Xiang J., Gaur S., Krebs J.F., Hoang K., Bai X., Korsmeyer S.J., Karanewsky D.S., Fritz L.C., Tomaselli K.J. Fas-induced activation of the cell death-related protease CPP32 is inhibited by Bcl-2 and by ICE family protease inhibitors. J. Biol. Chem. 271:1996;16850-16855.
31. Deshmukh M., Vasilakos J., Deckwerth T.L., Lampe P.A., Shivers B.D., Johnson E.M. Genetic and metabolic status of NGF-deprived sympathetic neurons saved by an inhibitor of ICE family proteases. J. Cell Biol. 135:1996;1341-1354.
32. Salvesen G.S., Dixit V.M. Caspases: intracellular signaling by proteolysis. Cell. 91:1997;443-446.
33. Xiang J., Chao D.T., Korsmeyer S.J. BAX-induced cell death may not require interleukin 1β-converting enzyme-like proteases. Proc. Natl. Acad. Sci. USA. 93:1996;14559.
34. Rossé T., Olivier R., Monney L., Rager M., Conus S., Fellay I., Jansen B., Borner C. Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature. 391:1998;496.
35. McCarthy N.J., Whyte M.K.B., Gilbert C.S., Evan G.I. Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes DNA damage or the Bcl-2 homologue Bak. J. Cell Biol. 136:1997;215.
36. Okuno S., Shimizu S., Ito T., Nomura M., Hamada E., Tsujimoto Y., Matsuda H. Bcl-2 prevents caspase-independent cell death. J. Biol. Chem. 273:1998;34272-34277.
37. Inohara N., Koseki T., Chen S., Wu X., Nuñez G. CIDE a novel family of cell death activators with homology to the 45 kDa subunit of the DNA fragmentation factor. EMBO J. 17:1998;2526-2533.
38. Olie R.A., Durrieu F., Cornillon S., Loughran G., Gross J., Earnshaw W.C., Golstein P. Apparent caspase independence of programmed cell death in Dictyostelium. Curr. Biol. 8:1998;955-958.
39. Chen X.M., Levine S.A., Tietz P., Kreuger E., McNiven M.A., Jefferson D.M., Mahle M., Larusso N.F. Cryptosporidium parvum is cytopathic for cultured human biliary epithelia via an apoptotic mechanism. Hepatololgy. 28:1998;906-913.
40. Ragland B.D., Ashley L.S., Vaux D.L., Petri W.A. Entamoeba histolytica: target cells killed by trophozoites undergo DNA fragmentation which is not blocked by Bcl-2. Exp. Parasitol. 79:1994;460-467.
41. Estaquier J., Marguerite M., Sahuc F., Bessis N., Auriault C., Ameisen J.C. Interleukin-10-mediated T cell apoptosis during the T helper type 2 cytokine response in murine Schistosoma mansoni parasite infection. Eur. Cytokine Net. 8:1997;153-160.
42. + T cell unresponsiveness during acute Toxoplasma gondii infection in mice. Int. Immunol. 8:1996;887-896.
43. + T cell death by apoptosis in experimental Chagas' disease. J. Immunol. 154:1995;744-752.
44. Chinnaiyan A.M., Woffendin C., Dixit V.M., Nabel G.J. The inhibition of pro-apoptotic ICE-like proteases enhances HIV replication. Nature M. 3:1997;333-337.
45. Upton S.J., Tilley M., Brillhart D.B. Comparative development of Cryptosporidium parvum (Apicomplexa) in 11 continuous host cell lines. FEMS Microbiol. Lett. 118:1994;233-236.
46. Flanigan T.P., Aji T., Marshall R., Soave R., Aikawa M., Kaetzel C. Asexual development of Cryptosporidium parvum within a differentiated human enterocyte cell line. Infect. Immun. 59:1991;234-239.
47. Goodgame R.W., Kimball K., Ou C.N., White A.C., Genta R.M., Lifschitz C.H., Chappell C.L. Intestinal function and injury in acquired immunodeficiency syndrome-related cryptosporidiosis. Gastroenterology. 108:1995;1075-1082.